386 related articles for article (PubMed ID: 28088184)
1. Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line.
Das D; Sengupta I; Sarkar N; Pal A; Saha D; Bandopadhyay M; Das C; Narayan J; Singh SP; Chakrabarti S; Chakravarty R
BMC Infect Dis; 2017 Jan; 17(1):76. PubMed ID: 28088184
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism.
Niu C; Li L; Daffis S; Lucifora J; Bonnin M; Maadadi S; Salas E; Chu R; Ramos H; Livingston CM; Beran RK; Garg AV; Balsitis S; Durantel D; Zoulim F; Delaney WE; Fletcher SP
J Hepatol; 2018 May; 68(5):922-931. PubMed ID: 29247725
[TBL] [Abstract][Full Text] [Related]
3. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
Zhang X; Ma Z; Liu H; Liu J; Meng Z; Broering R; Yang D; Schlaak JF; Roggendorf M; Lu M
J Hepatol; 2012 Sep; 57(3):522-8. PubMed ID: 22617154
[TBL] [Abstract][Full Text] [Related]
4. Anti-viral role of toll like receptor 4 in hepatitis B virus infection: An
Das D; Sarkar N; Sengupta I; Pal A; Saha D; Bandopadhyay M; Das C; Narayan J; Singh SP; Chakravarty R
World J Gastroenterol; 2016 Dec; 22(47):10341-10352. PubMed ID: 28058014
[TBL] [Abstract][Full Text] [Related]
5. Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1/2 pathway and down-regulating HNF4α and HNF1α in vitro.
Dai XQ; Cai WT; Wu X; Chen Y; Han FM
Life Sci; 2017 Jul; 180():68-74. PubMed ID: 28504115
[TBL] [Abstract][Full Text] [Related]
6. Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment.
Shi H; Lu L; Zhang NP; Zhang SC; Shen XZ
World J Gastroenterol; 2012 Jul; 18(27):3617-22. PubMed ID: 22826629
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of Toll-like receptor 7 expression in hepatitis-virus-related human hepatocellular carcinoma.
Lin KJ; Lin TM; Wang CH; Liu HC; Lin YL; Eng HL
Hum Pathol; 2013 Apr; 44(4):534-41. PubMed ID: 23069256
[TBL] [Abstract][Full Text] [Related]
8. Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C/EBP-β in hepatocytes.
Sarkar N; Panigrahi R; Pal A; Biswas A; Singh SP; Kar SK; Bandopadhyay M; Das D; Saha D; Kanda T; Sugiyama M; Chakrabarti S; Banerjee A; Chakravarty R
J Viral Hepat; 2015 Oct; 22(10):817-27. PubMed ID: 25720442
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates.
Zhou YB; Wang YF; Zhang Y; Zheng LY; Yang XA; Wang N; Jiang JH; Ma F; Yin DT; Sun CY; Wang QD
Eur J Pharmacol; 2012 May; 683(1-3):10-5. PubMed ID: 22387093
[TBL] [Abstract][Full Text] [Related]
10. Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells.
König A; Yang J; Jo E; Park KHP; Kim H; Than TT; Song X; Qi X; Dai X; Park S; Shum D; Ryu WS; Kim JH; Yoon SK; Park JY; Ahn SH; Han KH; Gerlich WH; Windisch MP
J Hepatol; 2019 Aug; 71(2):289-300. PubMed ID: 31077792
[TBL] [Abstract][Full Text] [Related]
11. Activating the innate immune response to counter chronic hepatitis B virus infection.
Lamb C; Arbuthnot P
Expert Opin Biol Ther; 2016 Dec; 16(12):1517-1527. PubMed ID: 27603796
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus sensitivity to interferon-α in hepatocytes is more associated with cellular interferon response than with viral genotype.
Shen F; Li Y; Wang Y; Sozzi V; Revill PA; Liu J; Gao L; Yang G; Lu M; Sutter K; Dittmer U; Chen J; Yuan Z
Hepatology; 2018 Apr; 67(4):1237-1252. PubMed ID: 29059468
[TBL] [Abstract][Full Text] [Related]
13. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
[TBL] [Abstract][Full Text] [Related]
14. miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytes.
Hou ZH; Han QJ; Zhang C; Tian ZG; Zhang J
Liver Int; 2014 Jan; 34(1):58-68. PubMed ID: 23890093
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
[TBL] [Abstract][Full Text] [Related]
16. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation.
Wei ZQ; Zhang YH; Ke CZ; Chen HX; Ren P; He YL; Hu P; Ma DQ; Luo J; Meng ZJ
World J Gastroenterol; 2017 Sep; 23(34):6252-6260. PubMed ID: 28974891
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor.
Jo E; Ryu DK; König A; Park S; Cho Y; Park SH; Kim TH; Yoon SK; Ryu WS; Cechetto J; Windisch MP
Antiviral Res; 2020 Mar; 175():104709. PubMed ID: 31940474
[TBL] [Abstract][Full Text] [Related]
18. Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.
Dusséaux M; Masse-Ranson G; Darche S; Ahodantin J; Li Y; Fiquet O; Beaumont E; Moreau P; Rivière L; Neuveut C; Soussan P; Roingeard P; Kremsdorf D; Di Santo JP; Strick-Marchand H
Gastroenterology; 2017 Dec; 153(6):1647-1661.e9. PubMed ID: 28851562
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance.
Lan P; Zhang C; Han Q; Zhang J; Tian Z
Hepatology; 2013 Jul; 58(1):73-85. PubMed ID: 23447417
[TBL] [Abstract][Full Text] [Related]
20. Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells.
Guo H; Jiang D; Ma D; Chang J; Dougherty AM; Cuconati A; Block TM; Guo JT
J Virol; 2009 Jan; 83(2):847-58. PubMed ID: 18971270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
